News tagged controlled-substances

NABP Seeks Individuals to Serve as Volunteer Item Writers for All NABP Exams

Topics: Education

NABP is seeking pharmacists and college/school of pharmacy faculty to volunteer as item writers for the North American Pharmacist Licensure Examination®, the Multistate Pharmacy Jurisprudence Examination® (MPJE®), the Foreign Pharmacy Graduate Equivalency Examination®, the Pharmacy Curriculum Outcomes Assessment®, and the Pharmacist Assessment for Remediation EvaluationSM.

Read More →

.Pharmacy gLTD and AWARXE Information Provided at Cardinal Health RBC Meeting, Drawing Winners Announced

Topics: Buying medicine online and Prescription drug abuse

Attendees who visited NABP’s booth at the Cardinal Health Retail Business Conference (RBC), held July 23-26, 2014, in Washington, DC, expressed their enthusiasm for the Association’s .Pharmacy generic Top-Level Domain (gTLD) Program and the AWARXE® Prescription Drug Safety Program.

Read More →

Attorney General Holder Urges Actions by Federal Agencies, Congress to Fight Opioid Abuse and Overdose

Topics: Prescription drug abuse

United States Attorney General Eric Holder is urging federal law enforcement agencies to “identify, train and equip personnel who may interact with a victim of a heroin overdose” to carry naloxone.

Read More →

DEA Reschedules Hydrocodone Combination Products as Schedule II

Topics: Controlled substances and Dea

Drug Enforcement Administration (DEA) has published its final rule rescheduling hydrocodone combination products from Schedule III to Schedule II in the Federal Register.

Read More →

FDA Approves New Abuse-Deterrent Opioid Pain Medication

Topics: Controlled substances and Fda

FDA has approved Targiniq™ ER, an opioid pain reliever designed to be more resistant to abuse.

Read More →

DEA Classifies Tramadol a Controlled Substance

Topics: Controlled substances and Fda

Under a final rule (PDF) published in the Federal Register, the pain reliever tramadol is now classified as a Schedule IV controlled substance (CS). 

Read More →

New Requirements for Some Painkiller Prescriptions Help to Lower Addiction Risk, Massachusetts Insurer Reports

Topics: Controlled substances

After implementing stricter requirements for certain painkiller prescriptions, Blue Cross and Blue Shield of Massachusetts, the state’s largest private health insurer, has released the results of an “18-month checkup.” 

Read More →

Massachusetts Cannot Ban Hydrocodone-Only Medications, Federal Judge Rules

Topics: Controlled substances and Fda

A US District Judge has ruled that Massachusetts may not ban the prescribing and dispensing of hydrocodone-only medication products that have been approved by FDA.

Read More →

Prescribers Can Play Important Role in Reducing Painkiller Overdose, CDC Reports

Topics: Controlled substances and Prescription drug abuse

People who frequently abuse opiate painkillers are often at the highest risk of overdosing, and are also likely to obtain the drugs through multiple prescriptions and multiple doctors, a practice known as “doctor shopping.”

Read More →

DEA Announces Temporary Scheduling of 10 Synthetic Cathinones

Topics: Controlled substances and Dea

The administrator of Drug Enforcement Administration (DEA) has issued a final order to temporarily schedule 10 synthetic cathinones into Schedule I of the Controlled Substances Act effective as of March 7, 2014. 

Read More →

DEA Publishes Proposed Rulemaking to Reschedule Hydrocodone Products, Invites Public Comment

Topics: Controlled substances, Prescription drug abuse, and Dea

New rules for hydrocodone combination products that would move the controlled substance medications from Schedule III to Schedule II have been proposed by Drug Enforcement Administration.

Read More →

New York’s Strengthened PMP Helped Cut “Doctor Shopping” by 75%

Topics: Controlled substances and Prescription drug abuse

Since the implementation of New York state’s Internet System for Tracking Over-Prescribing Act (I-STOP) in August 2013, “doctor shopping” – when patients visit multiple doctors to obtain controlled substance medications – has been reduced by 75%.

Read More →

NABP Collaborates With Health Care Stakeholders on Ensuring Delivery of Responsible and Effective Patient Care

Topics: Controlled substances and Patient safety

NABP, along with a coalition of health care industry stakeholders, has issued a consensus statement regarding the collaborative steps that will be taken to help ensure the delivery of responsible and effective patient care as it relates to the prescribing and dispensing of controlled substances.

Read More →

NABP Collaborates With Health Care Stakeholders on Ensuring Delivery of Responsible and Effective Patient Care

Topics: Controlled substances and Prescribing authority

The National Association of Boards of Pharmacy® (NABP®), along with a coalition of health care industry stakeholders, has issued a consensus statement regarding the collaborative steps that will be taken to help ensure the delivery of responsible and effective patient care as it relates to the prescribing and dispensing of controlled substances.

Read More →

Twitter Offers Insight into College Students’ Medication Misuse

Topics: Controlled substances and Prescription drug abuse

College students are taking to Twitter to talk about prescription drugs, often revealing how they misuse medications, according to two recent studies. 

Read More →

FDA to Recommend Reclassification of Hydrocodone Combination Products as Schedule II Controlled Substances

Topics: Controlled substances and Fda

Food and Drug Administration (FDA) plans to submit a formal recommendation to reclassify hydrocodone combination products as Schedule II controlled substances. 

Read More →

Pennsylvania House Passes Bill to Create Electronic Prescription Monitoring Program

Topics: Controlled substances and Prescription monitoring program

A Pennsylvania bill that would create a new prescription monitoring program to include Schedule II through V CS has passed the state’s House of Representatives.

Read More →

DEA Guidance Regarding Information Pharmacists May Provide on CS II Prescriptions

Topics: Controlled substances and Dea

Recognizing that pharmacists are sometimes presented with prescriptions for Schedule II controlled substances that are missing information required by law, Drug Enforcement Administration provides guidance for pharmacists regarding allowed changes or additions to such prescriptions.

Read More →

CVS Aggregates Data to Identify and Cut Off Suspected Pill Mills

Topics: Controlled substances and Diversion

In an effort to reduce prescription drug abuse, CVS pharmacists have adopted an analytical system to help identify “pill mill” prescribers.

Read More →

DEA to Hold Next Prescription Drug Take-Back Day on October 26, 2013

Topics: Controlled substances and Dea

Drug Enforcement Administration (DEA) will provide another opportunity for consumers to dispose of unneeded and expired prescription drugs during the 7th DEA National Prescription Drug Take-Back Day, October 26, 2013.

Read More →

Three Additional Synthetic Cannabinoids Classified as Schedule I Drugs

Topics: Controlled substances and Dea

DEA has issued a final order temporarily placing three synthetic cannabinoids into Schedule I of the Controlled Substances Act (CSA). 

Read More →

Legislation to Reschedule Products Containing Hydrocodone as Schedule II Drugs Introduced to Congress

Topics: Controlled substances and Prescription drug abuse

With the aim of curbing prescription drug abuse, bipartisan legislation that would reclassify drug products containing hydrocodone as Schedule II controlled substances (CS) was introduced to Congress on March 20, 2013.

Read More →

New York Doctor Pleads Guilty to Federal Charges of Illegally Distributing Oxycodone

Topics: Controlled substances, Diversion, and Dea

New York physician Felix Rodriguez pled guilty to the distribution of more than 1,000 oxycodone pills to individuals without legitimate medical need for the drug.

Read More →

Federal Legislation to Prevent Prescription Drug Abuse Introduced to Senate

Topics: Controlled substances and Prescription drug abuse

Aimed to address prescription drug misuse, addiction, and overdose deaths, the Prescription Drug Abuse Prevention and Treatment Act (SB 348) was reintroduced in the United States Senate.

Read More →

Philadelphia Doctor Sentenced to Seven-Year Prison Term for Illegal Distribution of Controlled Substance Medications

Topics: Controlled substances and Diversion

A Philadelphia doctor was sentenced to seven years in prison for charges related to a pill mill scheme that operated out of his office. 

Read More →

FDA Committee Recommends Schedule II Classification for Drugs Containing Hydrocodone

Topics: Controlled substances and Prescription drug abuse

The Food and Drug Administration (FDA) Drug Safety and Risk Management Advisory Committee recommended reclassifying hydrocodone combination products as Schedule II controlled substances after a two-day meeting.

Read More →

New York City Hospitals to Follow New Prescribing Guidelines Intended to Reduce Abuse of Painkillers

Topics: Controlled substances

To help reduce abuse and overdoses of prescription pain medications, New York City public hospitals will begin following new voluntary guidelines on prescribing.

Read More →

Available; Nationwide Disposal Sites to be Available September 29, 2012

Consumers can now quickly locate a site for safe disposal of unneeded and expired medications using the Drug Enforcement Administration (DEA) National Prescription Drug Take-Back Day Locator. DEA Take-Back Day collection sites will accept unwanted medications on September 29, 2012,...

Read More →

Idaho, Louisiana, and South Dakota Execute Agreements to Participate in NABP PMP InterConnect

Prescription monitoring programs (PMPs) in the states of Idaho, Louisiana, and South Dakota have executed a memorandum of understanding with NABP to participate in the NABP PMP InterConnect®, the system that facilitates the secure sharing of data between state PMPs,...

Read More →

Severe Health Risks Associated With Use of Reumofan Supplement Products, FDA Warns

Topics: Controlled substances, Federal regulations, and Adverse drug events

Food and Drug Administration (FDA) warns that consumers should not use Reumofan Plus products due to serious health risks related to the presence of prescription drug ingredients not listed on product labels. In a news release, FDA explains that the...

Read More →

Immune System Research May Lead to Drug for Treating and Preventing Opioid Addiction

Topics: Controlled substances, Prescription drug abuse, and Addiction recovery

New research on the immune system’s role in addiction may help scientists develop a drug to treat and prevent opioid addiction, including addiction to prescription painkillers. Focusing on the immune system’s response to opioids such as morphine, researchers from the...

Read More →

Online PMP Launched in Texas

Developed to help fight prescription drug abuse, the Texas Department of Public Safety (DPS) has launched an online prescription monitoring program (PMP) to provide controlled substance prescription dispensing history to authorized health care providers and law enforcement. The PMP, known...

Read More →

Groups Petition FDA to Change Opioid Labeling, Limit Long-term Use for Chronic, Non-Cancer Pain

Topics: Controlled substances, Federal regulations, and Pain management

Groups representing health care providers, researchers, and public health officials submitted a petition (PDF) requesting FDA to change opioid drug labeling so that indications for use in treating chronic, non-cancer pain would be limited. Supporters hope that such a change...

Read More →

Two Dietary Supplement Products Recalled Due to Presence of Sildenafil

Topics: Controlled substances and Buying medicine online

Manufacturer CRM Laboratories has initiated a voluntary recall of two products marketed as dietary supplements to support male sexual performance due to the presence of sildenafil and hydroxythiohomosildenafil. The products, X-ROCK 3 Day Pill For Men and Z-ROCK, were distributed...

Read More →

CSIP Announces Efforts to Combat Illegal Online Pharmacies

Topics: Controlled substances, Buying medicine online, and Internet pharmacy

In a partnership with the White House, the Center for Safe Internet Pharmacies (CSIP) will launch a campaign to help educate consumers about the dangers of unsafe prescription drugs often sold by illegal online pharmacies. The CSIP campaign will include...

Read More →

Lawmakers Introduce Bill to Require Abuse-Deterrent Formulations for Opioid Pain Drugs

A bill to require manufacturers to formulate tamper-proof versions of prescription opiate painkillers was introduced to the US House of Representatives on Thursday, July 19, 2012. With the aim of deterring abuse of the drugs, the Stop Tampering of Prescription...

Read More →

Abuse of Other Opioids Increased Following OxyContin Reformulation, Study Shows

Since the introduction of tamper-resistant OxyContin in 2010, abuse of other prescription opioids, as well as heroin, has increased, report researchers from Washington University in St Louis. The reformulated pill is more difficult to crush or dissolve, helping to prevent...

Read More →

REMS for Certain Opioids Approved by FDA

As part of the federal initiative to address the prescription drug abuse, misuse, and overdose epidemic, Food and Drug Administration (FDA) has approved a risk evaluation and mitigation strategy (REMS) for extended-release (ER) and long-acting (LA) opioids. The REMS introduces...

Read More →

Counterfeit Drug Distributor Convicted, Used Internet to Distribute Products

Topics: Controlled substances, Counterfeit drugs, and Diversion

Luis Angel Garcia Torres, of Patillas, Puerto Rico, was convicted of 12 counts in relation to the trafficking of counterfeit goods, including the trafficking of counterfeit pharmaceutical drugs over the Internet. A Department of Justice news release indicates that Torres...

Read More →

FDA Notifies Manufacturers to Stop Production and Distribution of Unapproved Oxycodone Products

Topics: Controlled substances and Federal regulations

Food and Drug Administration (FDA) has issued a Federal Register notice (PDF) instructing companies to stop manufacturing and distributing certain unapproved drugs that contain oxycodone. The agency indicates in a news release that the “action affects companies that manufacture and...

Read More →

New Michigan Law Bans Synthetic Drug Chemicals

Topics: Controlled substances

A new Michigan law bans synthetic cannabinoid products, including K2 and Spice, as well as synthetic bath salt products, and the chemicals used to make these products. These synthetic drugs will be classified as Schedule I controlled substances in Michigan...

Read More →

Federal Pill Mill Investigation Results in Multiple Arrests in Florida

Topics: Controlled substances, Diversion, and Prescription drug abuse

A multi-agency operation has resulted in charges against seven doctors and seven clinic owners on state racketeering violations related to the operation of illegal pain clinics throughout Florida. Drug Enforcement Administration (DEA) reports that the defendants “face 144 violations of...

Read More →

Large Scale New York Meth Investigation Results in 24 Indicted on PSE Smurfing-Related Charges

Topics: Controlled substances, Diversion, and Pseudoephedrine

Following a year-long investigation, 24 people have been indicted on charges related to the large scale manufacture and distribution of methamphetamine in central New York. The 24 individuals indicted have been charged with possession or distribution of pseudoephedrine (PSE) with...

Read More →

Florida Man Pleads Guilty to Federal Charges of Conspiracy to Distribute Synthetic Marijuana

Topics: Controlled substances, Diversion, and Federal regulations

Florida resident Joel Lester pleaded guilty to conspiring to possess with the intent to distribute synthetic marijuana on Friday, June 8, 2012, before the US District Judge Kenneth A. Marra. DEA reports that Lester owned Nature and Health, a business...

Read More →

Drug Counterfeiters Exploit Men's Health Risks, PSM Warns

Topics: Controlled substances, Counterfeit drugs, and Vipps vet vipps

Men’s health risks are often exploited by producers of counterfeit drugs as depicted in an infographic developed by the Partnership for Safe Medicines (PSM). PSM distributed the infographic in recognition of World Anti-Counterfeiting Day and Men's Health Week, and also...

Read More →

New LegitScript Search Tool Allows Consumers to Research Dietary Supplements for Safety Concerns

Topics: Controlled substances and Patient safety

A new search tool from LegitScript provides information on dietary supplements and other similar health care products indicating whether a product is known to be unsafe or marketed with unsupportable claims. The LegitScript Healthcare Product Search contains data on thousands...

Read More →

NY Legislation Would Change State's PMP Reporting Capabilities and Requirements and Reclassify Hydrocodone as Schedule II

Topics: Controlled substances and Prescription monitoring program

Aimed to help fight prescription drug abuse, proposed legislation in New York would change “the way prescription drugs are distributed and tracked” in the state. Attorney General Eric T. Schneiderman, Governor Andrew M. Cuomo, and New York legislators announced an...

Read More →

Counterfeit Adderall Purchased Online Contains Wrong Active Ingredients, FDA Warns

Topics: Controlled substances and Counterfeit drugs

Food and Drug Administration (FDA) is warning consumers and health care providers about a counterfeit version of Teva Pharmaceutical Industries’ Adderall® 30 mg tablets that is being purchased on the Internet. Adderall, a drug approved to treat attention deficit hyperactivity...

Read More →

Kentucky Law Bans Classes of Synthetic Drugs

Topics: Controlled substances

A new law in Kentucky bans entire classes of synthetic drugs, with the broader language intended to prevent producers from developing new formulas for the dangerous products often marketed as “bath salts” and “incense.” Kentucky Governor Steve Beshear stated that...

Read More →

Efforts to Investigate and Prosecute Synthetic 'Bath Salt' Distributors Intensify in Western Region of Virginia

Topics: Controlled substances

Working to locate synthetic “bath salt” drugs and “prosecute those who illegally distribute them,” the office of Timothy Heaphy, United States Attorney for the Western District of Virginia, has partnered with Drug Enforcement Administration (DEA), and state and local law...

Read More →

Amendment to Reclassify Hydrocodone as Schedule II Controlled Substance Passes US Senate

Topics: Controlled substances and Federal regulations

Aimed to help combat prescription drug abuse, an amendment to the FDA Safety and Innovation Act that would reclassify hydrocodone as a Schedule II controlled substance passed in the US senate on May 24, 2012. If adopted as law, “patients...

Read More →

Surescripts Provides Update on EPCS Prescribing in its Network to Assist Industry and Stakeholders

Topics: Controlled substances and Electronic prescriptions

Since Drug Enforcement Administration (DEA) issued the interim final rule for electronic prescribing of controlled substances (EPCS), a “modest number” of EPCSs have been transmitted across the Surescripts network, reports the company, which is the operator of the largest e-prescription...

Read More →

Most Young People Abusing Prescription Pain Drugs Begin at Age 16

Topics: Controlled substances and Prescription drug abuse

An estimated one in 30 to 40 teens began using prescription opioids non-medically at age 16, according to a new study. Researchers used data from the 2004 to 2008 National Survey on Drug Use and Health (NSDUH) to determine when...

Read More →

Federal CSIII Classification for PSE May Hold High Potential to Reduce Meth Trafficking and Abuse, NASCSA White Paper Concludes

Federal CSIII Classification for PSE May Hold High Potential to Reduce Meth Trafficking and Abuse, NASCSA White Paper Concludes Designating pseudoephedrine (PSE) as a Schedule III controlled substance (CS) at the federal level could have a high potential impact on...

Read More →

Montana Board's Prescription Drug Registry Now Accepting Data from Pharmacies

Topics: Controlled substances and Prescription monitoring program

Beginning on March 12, 2012, Montana’s Prescription Drug Registry, operated by the Montana Board of Pharmacy, began accepting data from pharmacies. Effective April 12, 2012, pharmacies are required to report controlled substances dispensing on a weekly basis, and are also...

Read More →

Washington Legislature Passes Bills Related to Practice of Pharmacy

The following bills passed in Washington State’s 2012 legislative session and may be of interest to the practice of pharmacy. HB1486 – This bill was reintroduced from 2010. The bill permits Washington State pharmacists to dispense controlled substance prescriptions written...

Read More →

DEA Take-Back Collection Site Locator Now Available

Now available online, the Drug Enforcement Administration (DEA) National Prescription Drug Take-Back Day collection site locator allows consumers to search for a convenient location to dispose of unneeded medications, including prescription pain pills and other controlled substance medications, on Saturday,...

Read More →

Timely CPE Programs Offer Attendees Up to Nine Contact Hours of CPE Credit at the NABP 108th Annual Meeting in Philadelphia

The National Association of Boards of Pharmacy® (NABP®) is offering attendees the opportunity to earn up to nine contact hours (0.9 CEUs) of Accreditation Council for Pharmacy Education-accredited continuing pharmacy education (CPE) credit at its 108th Annual Meeting. The meeting...

Read More →

North Dakota and South Carolina Deploy NABP PMP InterConnect; Seven States Now Live

Topics: Controlled substances, Diversion, and Prescription monitoring program

Prescription monitoring programs (PMPs) in North Dakota and South Carolina have gone live with the NABP PMP InterConnectSM, the system that facilitates the secure sharing of data between state PMPs, a key element for early detection, intervention, and prevention of...

Read More →

North Carolina Now Requires Photo Identification to Pick Up Certain CS Medications

Topics: Controlled substances, Pharmacies, and Pharmacy staff

Effective March 1, 2012, a North Carolina law requires recipients of certain CS prescription medications to present an acceptable government-issued photo identification to pharmacy staff prior to receiving the dispensed medication. The law applies to all Schedule II CS and...

Read More →

NABP Urges ICANN to Take Action to Protect Public Health From Domain Registrars Enabling Rogue Online Pharmacies

LegitScript Investigation Finds Registrar Facilitating Fake Pharmacies’ Unlawful Activities The National Association of Boards of Pharmacy® (NABP®) has contacted the Internet Corporation for Assigned Names and Numbers (ICANN) urging the organization to take action against Internet.bs, a Web site registrar...

Read More →

DEA Issues Proposed Regulations Placing Five Synthetic Cannabinoids into Schedule I

Topics: Controlled substances and Federal regulations

Drug Enforcement Administration (DEA) has issued a proposed rule placing five synthetic cannabinoids into Schedule I of the Controlled Substances Act (CSA). The proposed rule was published in the March 1, 2012, Federal Register and extends the final order that...

Read More →

2011-2012 Report of the Task Force on the Control and Accountability of Prescription Medications Released

Topics: Controlled substances and Committee and task force reports

The Task Force on the Control and Accountability of Prescription Medications met October 26-27, 2011. This task force was established in response to Resolution 107-3-11, Control and Accountability of Prescription Medications, which was approved by the NABP membership at the...

Read More →

Mid-Level Practitioner Controlled Substance

Topics: Controlled substances

Originally  published in the February 2012 Missouri Board of Pharmacy Newsletter. The Bureau of Narcotics and Dangerous Drugs (BNDD) is now issuing controlled substance registrations to advanced practice registered nurses (APRNs) and physician assistants (mid-level practitioners). As of December 1, 2011,...

Read More →

Legislation to Require Valid Prescription for Non-CS Prescription Drugs Ordered Online Introduced to US Senate

Topics: Controlled substances

The Online Pharmacy Safety Act (S 2002), a bill developed to protect consumers from Internet drug outlets that distribute drugs without requiring a valid prescription, was introduced to the United States Senate on December 15, 2011. The legislation builds on...

Read More →

Regulators Review Reverse Distribution Process to Prevent Diversion, Environmental Hazards

Topics: Controlled substances

Originally published in the January 2012 NABP Newsletter. Regulators have renewed focus on the reverse distribution process in the context of a national prescription drug abuse epidemic, which creates a market for diverted drugs, and national concerns for the safety...

Read More →

DEA Announces Temporary Scheduling of Three Synthetic Cathinones and Proposed Scheduling of Ezogabine

Topics: Controlled substances

The administrator of the DEA has issued a final order to temporarily schedule three synthetic cathinones – 4-methyl-Nmethylcathinone (mephedrone), 3,4- methylenedioxy-N-methylcathinone (methylone), and 3,4- methylenedioxypyrovalerone (MDPV) – placing them into Schedule I of the Controlled Substances Act (CSA) effective as...

Read More →

Nearly 20 Products Marketed as Natural Supplements Contain Sibutramine, FDA Warns

Topics: Controlled substances

FDA has posted public warnings regarding 19 products, frequently marketed as natural supplements, and found to contain sibutramine, a controlled substance that was removed from the US market in October 2010 for safety reasons. These products pose a threat to...

Read More →

DEA Guidance Regarding Information Pharmacists May Provide on CS II Prescriptions

Topics: Controlled substances

Recognizing that pharmacists are sometimes presented with prescriptions for Schedule II controlled substances (CS) that are missing information required by law, Drug Enforcement Administration (DEA) provides guidance (PDF) for pharmacists regarding allowed changes or additions to such prescriptions. First, DEA...

Read More →

Illinois Man Guilty of Distributing Controlled Substances Via Internet Drug Outlets

Topics: Controlled substances

Steven Immergluck of Aurora, IL pleaded guilty to conspiracy to distribute and dispense controlled substances and to using the Internet to facilitate a drug crime. According to a Department of Justice press release, the government had evidence to prove that...

Read More →

Ohio Physician Convicted for Illegally Prescribing and Dispensing Pain Pills

Topics: Controlled substances

Convicted by a US District Court jury of illegally prescribing and dispensing millions of pain pills outside the scope of a legitimate medical practice, Dr Paul H. Volkman faces at least 20 years in prison. At the conclusion of a...

Read More →

Washington Bans 'Bath Salt' Chemicals Through Extended Rule on Illegal Synthetic Cannabinoids

Topics: Controlled substances

The Washington State Board of Pharmacy filed a second emergency rule, WSR 11-09-044 (PDF), to extend the state’s ban on synthetic cannabinoid chemicals and include chemicals used in "bath salts." The rule, adopted on April 15, 2011, effectively keeps illegal...

Read More →

Florida House Considers Legislation to Fight Pill Mills

Topics: Controlled substances and Prescription monitoring program

In Florida, legislation aimed to fight unscrupulous pain clinics, or “pill mills,” is being considered by the state House of Representatives. After revisions, including the removal of a provision that would have repealed the state’s prescription drug monitoring program law,...

Read More →

CS Prescriptions for Teens Increase to Nearly Twice 1994 Levels

Topics: Controlled substances and Prescription drug abuse

One in nine adolescents received a prescription for medications with a high potential for abuse in 2007, a rate almost twice the 1994 levels, according to a study published in the December 2010 issue of Pediatrics. The researchers did not...

Read More →

New Jersey Issues Medical Marijuana Regulations

Topics: Controlled substances and Medical marijuana

Following some debate among New Jersey Governor Chris Christie and the state’s General Assembly, regulations to implement the New Jersey medical marijuana law have been agreed upon. The regulations will allow for six alternative treatment centers that will both dispense...

Read More →

Iowa Board Supports Bill to Classify Marijuana as Schedule II

Topics: Controlled substances and Medical marijuana

Proposed legislation that would amend the Iowa code to classify marijuana as a Schedule II drug was approved in a vote by the Iowa Board of Pharmacy on Wednesday, November 24, 2010. Such a change would allow for medical uses...

Read More →

Iowa Board Approved Medical Marijuana Recommendation to Legislature

Topics: Controlled substances

As a follow-up to the decision made in February 2010, the Iowa Board of Pharmacy approved its recommendation to the Iowa Legislature that marijuana be reclassified as a Schedule II controlled substance, on November 2, 2010. The Iowa Board’s February...

Read More →

Secure and Responsible Drug Disposal Act Signed Into Law

Topics: Controlled substances

President Obama signed into law the Secure and Responsible Drug Disposal Act (S 3397) on October 12, 2010. The law amends the Controlled Substances Act to give the Attorney General authority to promulgate regulations to allow patients to deliver unused...

Read More →

DEA Issues Policy Statement on Role of Agents in Communicating CS Prescriptions

Topics: Controlled substances

Drug Enforcement Administration (DEA) issued a statement of policy that clarifies the proper role of a duly authorized agent of a DEA-registered individual practitioner in communicating controlled substance (CS) prescription information to a pharmacy. The statement, published October 6, 2010,...

Read More →

Secure and Responsible Drug Disposal Act Presented to President Obama

Topics: Controlled substances

Developed to address the growing rates of prescription drug abuse, the Secure and Responsible Drug Disposal Act (S 3397) has passed in the United States Senate and House and was presented to President Obama on September 30, 2010. This act...

Read More →

US House Passed Act to Combat Illegal Methamphetamine Production

Topics: Controlled substances

If signed into law by President Obama, the Combat Methamphetamine Enhancement Act of 2010 (HR 2923) would amend the Controlled Substances Act to effectively require all regulated retail sellers of drug products containing methamphetamine precursors to submit to the Attorney...

Read More →

NABP Commissions Task Force to Review CSA

Topics: Controlled substances and Committee and task force reports

Originally published in the October 2010 NABP Newsletter Recommended Changes will Focus on Facilitating Provision of Patient Care and Protecting the Public Health From policies guiding allowable Schedule II prescription changes by pharmacists, to regulations for secure disposal of unused...

Read More →

Iowa Law Enforcement Seeks Assistance in Tracking Group Using Fraudulent CS Prescriptions

Topics: Controlled substances

The Iowa Department of Public Safety seeks assistance in tracking a group of individuals using fraudulent prescriptions to obtain controlled substances. Specifically, four unidentified individuals have obtained oxycodone using fraudulent prescriptions at a number of pharmacies in Iowa. Similar cases...

Read More →

Oregon Board Classifies Marijuana as Schedule II Drug in Accordance with OR Law

Topics: Controlled substances

On June 16, 2010 the Oregon State Board of Pharmacy acted to reclassify marijuana as a Schedule II controlled substance in accordance with an Oregon law that passed last year. The new law requires that marijuana be removed from a...

Read More →

DEA Instructs Pharmacists to Adhere to State Regulations Regarding Schedule II Prescription Changes

Topics: Controlled substances

Drug Enforcement Administration (DEA) advises that pharmacists should adhere to state regulations or policy regarding changes that a pharmacist may make to a Schedule II prescription after oral consultation with the prescriber. DEA recognizes that there may be confusion regarding...

Read More →

Kansas News: Changes to a Schedule II Prescription

Topics: Controlled substances

Published in the June 2010 Kansas State Board of Pharmacy Newsletter The Kansas State Board of Pharmacy and Drug Enforcement Administration (DEA) have “Frequently Asked Questions” on their Web pages to assist medical care professionals. There was much confusion recently...

Read More →

Rogue Drug Site Operators Indicted for Conspiracy to Distribute Controlled Substances

Topics: Controlled substances and Internet pharmacy

A superseding indictment charges two individuals, Carleta Carolina and Wayne White, with conspiracy to distribute controlled substances and other charges as part of their involvement in a large-scale rogue Internet drug outlet operation. DEA Special Agent in Charge, John J....

Read More →

States Continue to Develop Medical Marijuana Policies as Federal Stance Remains Firm

Topics: Controlled substances

With the recent Iowa Board of Pharmacy recommendation that marijuana be reclassified as a Schedule II controlled substance, Iowa may be one of the next states to enact legislation legalizing the use of medical marijuana under certain circumstances. To date,...

Read More →

DEA Announces Hearing Regarding Placement of Carisoprodol Into Schedule IV

Topics: Controlled substances

Drug Enforcement Administration (DEA) has announced a hearing regarding the proposed placement of carisoprodol in schedule IV of the Controlled Substances Act, a rule that was proposed on November 17, 2009. The hearing will take place May 4, 2010, in...

Read More →

Alabama News: Prescribing of Controlled Substances by Physician Assistants

Topics: Controlled substances and Prescribing authority

Published in the November 2009 Alabama State Board of Pharmacy Newsletter A new law authorizes qualified, approved physician assistants (PAs) to prescribe controlled substances in Schedules III, IV, and V. The Alabama Board of Medical Examiners is in the process...

Read More →

North Carolina News: Item 2192 - Clinical Pharmacist Practitioner Prescriptions for Controlled Substances

Topics: Controlled substances and Prescriptions

Reprinted from the October 2009 North Carolina Board of Pharmacy Newsletter. Board staff occasionally are asked about the legitimacy of prescriptions for controlled substances written by a clinical pharmacist practitioner (CPP). There are typically two questions asked: 1. May a...

Read More →

Washington News: Board of Pharmacy Schedules Carisoprodol

Topics: Controlled substances

Published in the October 2009 Washington State Board of Pharmacy Newsletter At the September 17, 2009 Washington State Board of Pharmacy meeting, the Board changed rules to add the drug carisoprodol to Schedule IV controlled substances. After considering evidence and...

Read More →

Minnesota News: 2009 Legislation Affecting the Practice of Pharmacy

Reprinted from the October 2009 Minnesota Board of Pharmacy Newsletter. A large number of bills related to the profession of pharmacy or to pharmaceutical manufacturers were introduced this past session. Descriptions of some of the provisions that were enacted into...

Read More →

Minnesota News: New Prescription Monitoring Program

Topics: Controlled substances and Prescription monitoring program

Reprinted from the October 2009 Minnesota Board of Pharmacy Newsletter. The Minnesota Legislature passed a law in 2007 requiring the Board of Pharmacy to establish a controlled substances prescription electronic reporting system for all Schedule II and III controlled substance...

Read More →

Nevada News: Reminder

Topics: Controlled substances and Electronic prescriptions

Reprinted from the October 2009 Nevada State Board of Pharmacy Newsletter. 1. Computer-generated prescriptions that are either printed or faxed must be signed by the practitioner. If the printed and signed prescription is to be given to the patient to...

Read More →

Delaware News: Controlled Substance Issues

Topics: Controlled substances

Published in the September 2009 Delaware State Board of Pharmacy Newsletter Refilling Controlled Substance Prescriptions Early The Board office has recently had numerous calls related to the early refilling of controlled substance prescriptions. There is no easy way to determine...

Read More →

North Carolina News: Item 2186 - Progress of Drug Enforcement Administration's Controlled Substance Electronic Prescribing Rulemaking

Topics: Controlled substances and Electronic prescriptions

Reprinted from the July 2009 North Carolina Board of Pharmacy Newsletter. As previously reported, in June 2008, the Drug Enforcement Administration (DEA) proposed a rule that would permit electronic prescribing for all schedules of controlled substances. The public comment period...

Read More →

Delaware News: Controlled Substance Records and Inventory Requirements

Topics: Controlled substances

Published in the June 2009 Delaware State Board of Pharmacy News As a reminder, controlled substance inventories must be taken at least biennially after the initial inventory is taken. The biennial inventory may be taken on any date that is...

Read More →

Over-prescribing and Excessive Use of Controlled Substances and Other Prescription Medications (Resolution No. 105-2-09)

Topics: Controlled substances and Resolutions

Resolution No. 105-2-09 Title: Over-prescribing and Excessive Use of Controlled Substances and Other Prescription Medications Action: Passed Whereas, state boards of pharmacy are aware that prescription medications, including controlled substances, are being over-prescribed and used excessively, contributing to access and...

Read More →

North Carolina News: Item 2182 - North Carolina Controlled Substance Reporting System

Reprinted from the April 2009 North Carolina Board of Pharmacy Newsletter. Pharmacists in the state are aware that the General Assembly enacted a Controlled Substance Reporting System in 2006, and that the system has been operative for over a year....

Read More →

Idaho News: Rules for Prescription Transmission to a Non-Institutional Pharmacy

Topics: Controlled substances and Prescriptions

Published in the March 2009 Idaho State Board of Pharmacy Newsletter 1. What are the prescription transmission rules for legend drugs in general? Refer to Idaho Statute 54.1733(d). The options are summarized as follows: Original practitioner-signed prescription Fax of original...

Read More →

Kansas News: Board Adds BZP to Schedule I List

Topics: Controlled substances

Published in the March 2009 Kansas State Board of Pharmacy Newsletter The Board of Pharmacy added BZP to its Schedule I list. BZP is the common name for the synthetic drug Nbenzylpiperazine, a stimulant that is approximately 10 to 20...

Read More →

Kansas News: Changes on a Schedule II Prescription

Topics: Controlled substances and Prescriptions

Published in the March 2009 Kansas State Board of Pharmacy Newsletter On November 19, 2007, Drug Enforcement Administration (DEA) published in the Federal Register the Final Rule entitled Issuance of Multiple Prescriptions for Schedule II Controlled Substances (72 FR 64921)....

Read More →

New Mexico News: Prescription Monitoring Program

Topics: Controlled substances and Prescription monitoring program

Published in the March 2009 New Mexico Board of Pharmacy Newsletter Every pharmacy in New Mexico has been set up to receive patient utilization reports of controlled substances dispensed. The pharmacist-in-charge can register with the program online and receive a...

Read More →

Delaware News: DEA Update: Multiple Schedule II Prescriptions with Different Dates

Topics: Controlled substances, Federal regulations, and Prescriptions

Published in the March 2009 Delaware State Board of Pharmacy Newsletter As a reminder, multiple Schedule II prescriptions for the same patient with different dates are permitted. Prescriptions must be written with the date of issue, may not exceed 90...

Read More →

Ohio News: Last Minute Bills Approved by the Legislature

Topics: Controlled substances and Pharmacy technicians

Published in the February 2009 Ohio State Board of Pharmacy Newsletter During the last session of the 127th General Assembly, several bills were approved by the Legislature that could affect pharmacy practice. There were also several bills that did not...

Read More →

Nebraska News: Controlled Substance Answers Here

Topics: Controlled substances

Published in the February 2009 Nebraska Board of Pharmacy Newsletter Looking for answers to your controlled substances or Drug Enforcement Administration (DEA) questions? DEA has a terrific Web site: www.deadiversion.usdoj.gov/. The site contains lists of controlled substances by schedule, order...

Read More →

Nebraska News: Count 'Em Annually

Topics: Controlled substances

Published in the February 2009 Nebraska Board of Pharmacy Newsletter Nebraska pharmacists are reminded that the 2008 Nebraska Legislature passed LB 902, which requires that pharmacies conduct a controlled substances inventory annually beginning January 1, 2009. The inventory was previously...

Read More →

Minnesota News: E-Prescribing and Controlled Substances

Topics: Controlled substances and Electronic prescriptions

Reprinted from the January 2009 Minnesota Board of Pharmacy Newsletter. The Board frequently receives questions from pharmacists concerning the legal validity of controlled substance prescriptions that have been electronically “signed.” Such prescriptions may have the electronically captured signature of the...

Read More →

Nevada News: Regulatory Update

Topics: Controlled substances

Reprinted from the January 2009 Nevada State Board of Pharmacy Newsletter. For the betterment of the practice of pharmacy and ultimately for the benefit of the patient, the Nevada State Board of Pharmacy has been quite active on the regulatory...

Read More →

Oklahoma News: Update on E-Signatures

Topics: Controlled substances and Electronic prescriptions

Published in the January 2009 Oklahoma State Board of Pharmacy Newsletter Electronic signatures for noncontrolled prescriptions are considered valid. E-mailed Schedule III to V controlled prescriptions must contain a manual signature to be valid at this time. If they are...

Read More →

Kansas News: Prescriptions for Obesity

Topics: Controlled substances and Prescriptions

Published in the December 2008 Kansas State Board of Pharmacy Newsletter In March 2007, the legislative pharmacists on the Kansas State House and Senate were instrumental in removing the requirement that a prescription for amphetamines or sympathomimetic amines designated in...

Read More →

Idaho News: Authorization to "Refill" Received Via Fax

Topics: Controlled substances and Prescriptions

Published in the December 2008 Idaho State Board of Pharmacy Newsletter Rule 447.03 requires that “additional quantities of controlled substances . . . only be authorized . . . through the issuance of a new prescription.” Statute 54-1732 (3)(b) mandates...

Read More →

Idaho News: Changes Pharmacists May Make to Schedule II Prescriptions

Topics: Controlled substances and Prescriptions

Published in the December 2008 Idaho State Board of Pharmacy Newsletter On November 19, 2007, Drug Enforcement Administration (DEA) stated in a preamble to the Final Rule on Issuance of Multiple Prescriptions for Schedule II Controlled Substances that “the essential...

Read More →

Ohio News: Electronic Prescribing Issues

Topics: Controlled substances and Electronic prescriptions

Published in the November 2008 Ohio State Board of Pharmacy Newsletter On June 27, 2008, the Drug Enforcement Administration (DEA) published proposed rules for the electronic prescribing of controlled substances. The comment period for these rules ended on September 25,...

Read More →

Oregon News: Emergency Schedule II Prescriptions

Topics: Controlled substances

Published in the November 2008 Oregon State Board of Pharmacy Newsletter Approximately one year ago, the Board of Pharmacy presented an article to the Oregon Board of Medical Examiners for inclusion in its newsletter describing the practitioner’s responsibility when calling...

Read More →

New Jersey News: Recognizing Fraudulent Prescriptions

Topics: Controlled substances and Counterfeit drugs

Reprinted from the October 2008 New Jersey Board of Pharmacy Newsletter. Fraudulent prescriptions for controlled dangerous substances continue to present a significant problem to dispensing pharmacists. A Web page entitled “A Pharmacist’s Guide to Prescription Fraud,” published by the Drug...

Read More →

Minnesota News: The Internet and the Abuse of Prescription Drugs (Part 1)

Topics: Controlled substances, Internet pharmacy, and Prescription drug abuse

Reprinted from the October 2008 Minnesota Board of Pharmacy Newsletter. As noted in this issue’s Disciplinary Actions, the Board recently disciplined five pharmacists and one pharmacy for involvement with Internet Web sites that offered to arrange for the sale of...

Read More →

Nevada News: Inspector's Corner

Topics: Controlled substances and Prescriptions

Reprinted from the October 2008 Nevada State Board of Pharmacy Newsletter. The scenario is as follows: A patient tenders a Schedule II prescription within the 14-day window as required and asks the pharmacist to hold it for filling at a...

Read More →

Vermont News: New Laws Regarding Schedule II Drugs

Topics: Controlled substances and Prescriptions

Published in the September 2008 Vermont Board of Pharmacy Newsletter (Title 18 VSA §4215. Authorized Sales By Pharmacists) In the last three years the Board of Pharmacy has received numerous comments and complaints about the rule that required prescriptions for...

Read More →

Kentucky News: Changes to Controlled Substance Prescriptions

Topics: Controlled substances and Prescriptions

Published in the September 2008 Kentucky Board of Pharmacy Newsletter KRS 217.216, 218A.180(4), and 902 KAR 55:105 require the following items on a written prescription for a controlled substance: Date of issue Quantity check-off boxes marked Patient’s name Directions for...

Read More →

New Mexico News: Electronic Controlled Substance Prescriptions

Topics: Controlled substances and Electronic prescriptions

Published in the September 2008 New Mexico Board of Pharmacy Newsletter An electronically generated controlled substance prescription that is not manually signed by the practitioner, but instead is electronically signed, is not valid. A written prescription for a controlled substance...

Read More →

Idaho News: 2008 Statute and Rule Changes

Topics: Controlled substances and Pharmacy technicians

Published in the September 2008 Idaho Board of Pharmacy Newsletter Rule 464. Filling Controlled Substance Prescription and Positive Identification: Persons receiving controlled substances shall be positively identified by the staff at the pharmacy at the time any controlled substance is...

Read More →

Delaware News: Controlled Substance Issues Frequently Asked Questions

Topics: Controlled substances and Prescriptions

Published in the September 2008 Delaware State Board of Pharmacy Newsletter Transfer of Controlled Substances between Pharmacies 21 CFR 1306.25 (a) The transfer of original prescription information for a controlled substance listed in Schedules III, IV, or V for refill...

Read More →

Ohio News: Optometrists and Controlled Substances

Topics: Controlled substances and Prescribing authority

Published in the August 2008 Ohio State Board of Pharmacy Newsletter The Ohio State Board of Optometry rule that deals with optometrists’ prescribing of controlled substances for pain was due to go before the Joint Committee on Agency Rule Review...

Read More →

Minnesota News: 2008 Legislation Affecting Pharmacy

Topics: Controlled substances and Electronic prescriptions

Reprinted from the July 2008 Minnesota Board of Pharmacy Newsletter. Several laws were passed this year that will have an impact on the practice of pharmacy. Most of the pharmacy provisions in Chapter 321 of 2008 Session Law were drafted...

Read More →

Vermont News: Electronic Prescribing of Controlled Substances

Topics: Controlled substances and Electronic prescriptions

Published in the June 2008 Vermont Board of Pharmacy Newsletter Is it legal for a licensed prescriber to create electronic prescriptions for Schedule III through V drugs on his or her e-prescribing software and transmit them electronically to either the...

Read More →

Montana News: "Office Use" Prescriptions

Topics: Controlled substances and Prescription transfer

Reprinted form the April 2008 Montana Board of Pharmacy Newsletter. A recent question to the Board office asked whether an “office use” prescription is valid. The answer is no. Medications prescribed must be dispensed to a patient. When medication is...

Read More →

Montana News: New DEA rule regarding Multiple Prescriptions for Schedule II Controlled Substances

Topics: Controlled substances and Prescriptions

Reprinted form the April 2008 Montana Board of Pharmacy Newsletter. DEA has issued a final rule entitled “Issuance of Multiple Prescriptions for Schedule II Controlled Substances,” effective December 19, 2007. Practitioners may now provide a patient with multiple prescriptions for...

Read More →

South Dakota News: Multiple Schedule II Prescriptions

Topics: Controlled substances and Prescriptions

Published in the April 2008 South Dakota State Board of Pharmacy Newsletter Effective December 19, 2007, Drug Enforcement Administration released a new rule amendment to Title 21 Code of Federal Regulations Part 1306 authorizing prescribers to provide individual patients with...

Read More →

North Carolina News: Item 2164 - Changes to Schedule II Prescriptions

Topics: Controlled substances

Reprinted from the April 2008 North Carolina Board of Pharmacy Newsletter. The frequently asked questions section of the Board’s Web site provides guidance on changes that may be made to a prescription for a Schedule II controlled substance after consultation...

Read More →

Nevada News: Prescription Refills

Topics: Controlled substances and Prescription refills

Reprinted form the April 2008 Nevada State Board of Pharmacy Newsletter. Board staff often gets a call from either a patient or a pharmacist asking if it is OK for a pharmacist to fill multiple refills for the same prescription...

Read More →

Idaho News: Multiple Schedule II Prescriptions

Topics: Controlled substances and Prescriptions

Published in the March 2008 Idaho Board of Pharmacy Newsletter Effective December 19, 2007, DEA amended a regulation to allow practitioners to provide an individual patient with multiple prescriptions for a specific Schedule II CS, written on the same date,...

Read More →

Kentucky News: KASPER Data Collection Update

Topics: Controlled substances and Prescription monitoring program

Published in the March 2008 Kentucky Board of Pharmacy Newsletter On February 18, 2008, all Kentucky All Schedule Prescription Electronic Reporting (KASPER) data collection will be through RelayHealth. Recent communications to dispensers of controlled substances in Kentucky have highlighted the...

Read More →

Delaware News: Electronic Transmission of Controlled Substance Prescriptions

Topics: Controlled substances and Electronic prescriptions

Published in the March 2008 Delaware State Board of Pharmacy Newsletter There have been a number of recent inquiries and some confusion regarding the validity of electronically transmitted controlled substance prescriptions from a practitioner’s office to a pharmacy. E-prescribed controlled...

Read More →

Missouri News: Waivers Required to Employ Certain Individuals

Topics: Controlled substances

Published in the February 2008 Missouri Board of Pharmacy Newsletter Any pharmacy or drug distributor who employs or wishes to employ an individual who has entered a plea of guilty, no contest, nolo contendere, or otherwise been convicted of a...

Read More →

Alabama News: Multiple Schedule II Prescriptions

Topics: Controlled substances

Published in the February 2008 Alabama State Board of Pharmacy Newsletter Effective December 19, 2007, DEA released a new rule amendment to Title 21 Code of Federal Regulations Part 1306 authorizing prescribers to provide individual patients with multiple prescriptions for...

Read More →

North Carolina News: Item 2155 - DEA Adopts Rule Allowing Multiple Prescriptions for Schedule II Controlled Substances

Topics: Controlled substances

Reprinted from the January 2008 North Carolina Board of Pharmacy Newsletter. The Drug Enforcement Administration (DEA) published in the Federal Register on November 19, 2007, a final rule titled “Issuance of Multiple Prescriptions for Schedule II Controlled Substances.” The rule...

Read More →

Minnesota News: DEA Adopts Rule Change Regarding Schedule II Prescriptions

Topics: Controlled substances and Prescription refills

Reprinted from the January 2008 Minnesota Board of Pharmacy Newsletter. Drug Enforcement Administration adopted the following rule change effective December 19, 2007. The issuance of multiple prescriptions as described in this rule change is permissible under Minnesota law. Sec. 1306.12...

Read More →

Washington News: New Federal Drug Enforcement Rules - Multiple Prescriptions

Topics: Controlled substances and Prescriptions

Published in the January 2008 Washington State Board of Pharmacy Newsletter DEA amended regulations to allow practitioners to provide individual patients with multiple prescriptions for the same Schedule II CS written on the same date, to be filled sequentially. The...

Read More →

North Carolina News: Item 2151 - Wholesale Prescription Drug Distributors Laws' Applicability to Pharmacies

Topics: Controlled substances, Prescription transfer, and Pedigrees

Reprinted from the October 2007 North Carolina Board of Pharmacy Newsletter. Board staff is frequently asked whether and under what circumstances a transfer of prescription drugs to another pharmacy could trigger wholesaler obligations. Dan Ragan – the drug administrator for...

Read More →

Minnesota News: Changing Information on Schedule II Prescriptions

Topics: Controlled substances

Reprinted from the October 2007 Minnesota Board of Pharmacy Newsletter. Board staff members are often asked about what information can be changed (or added) to a Schedule II prescription by a pharmacist. The following answer, which is posted on the...

Read More →

Montana News: Changing Information on Schedule II

Topics: Controlled substances and Prescribing authority

Reprinted from the October 2007 Montana Board of Pharmacy Newsletter. The United States Drug Enforcement Administration (DEA) provides information on what can be changed or added to a Schedule II controlled substance prescription by a pharmacist. The majority of changes...

Read More →

New Mexico News: Who Is Responsible?

Topics: Controlled substances

Published in the September 2007 New Mexico Board of Pharmacy Newsletter. This year there have been numerous issues involving the delivery of CS from drug wholesalers. These issues can include shipping overages, shortages, receipt of items not ordered, or something different...

Read More →

Alabama News: Controlled Substance Registration Waiver

Topics: Controlled substances

Published in the August 2007 Alabama State Board of Pharmacy Newsletter The Alabama Uniform Controlled Substances Act mandates that every person or entity who manufacturers, distributes, or dispenses any controlled substance (CS) within Alabama or who proposes to do so...

Read More →

Kentucky News: ARNP Controlled Substance Prescription Limitations

Topics: Controlled substances and Prescriptions

Published in the June 2007 Kentucky Board of Pharmacy Newsletter Beginning March 9, 2007, additional limitations were placed on the prescriptive authority of advanced registered nurse practitioners (ARNP) for controlled substances (CS) by the Kentucky Board of Nursing. Following are...

Read More →

Missouri News: Electronic Transmission of Controlled Substance Prescriptions

Topics: Controlled substances

Published in the May 2007 Missouri Board of Pharmacy Newsletter Board of Pharmacy regulation 20 CSR 2220-2.085 allows for the transmission of controlled substance (CS) prescriptions by electronic transmission as long as it does not violate other state or federal...

Read More →

Alabama News: Alabama Department of Public Health - News Release

Topics: Controlled substances

Published in the May 2007 Alabama State Board of Pharmacy Newsletter Butalbital compounds will be under stricter control. The State Committee of Public Health has approved a rule change that will remove any exemptions on butalbital compounds from the Alabama...

Read More →

Montana News: Answers to Frequently Asked Questions

Topics: Controlled substances

Reprinted from the April 2007 Montana Board of Pharmacy Newsletter. Is there a quantity limit on Schedule II prescriptions? According to federal law, there is no quantity limit for controlled substances (CS) prescriptions, including Schedule II prescriptions. However, a pharmacist...

Read More →

North Carolina News: Item 2137 - Roll Out of the Controlled Substances Reporting Act

Topics: Controlled substances

Reprinted from the April 2007 North Carolina Board of Pharmacy Newsletter. Most pharmacists are aware that the General Assembly enacted a CS reporting system last year. The statute requires all dispensers to report information about CS prescriptions to the state...

Read More →

North Carolina News: Item 2136 - Illegal Internet Operations Continue to Solicit Independent Pharmacies in North Carolina

Topics: Controlled substances and Internet pharmacy

Reprinted from the April 2007 North Carolina Board of Pharmacy Newsletter. Previous Newsletter items have alerted independent pharmacists that illegal Internet operations are soliciting them to act as “fulfillment” centers. This continues to occur. The typical “pitch” is that an...

Read More →

Vermont News: Faxed Schedule II Prescriptions for Hospice Patients

Topics: Controlled substances and Prescriptions

Published in the March 2007 Vermont Board of Pharmacy Newsletter The Board of Pharmacy would like to clarify the rules regarding faxed Schedule II prescriptions for a hospice patient. According to the federal Controlled Substances Act as found in Code...

Read More →

New Mexico News: Controlled Substance Prescriptions

Topics: Controlled substances, Diversion, and Prescriptions

Published in the March 2007 New Mexico Board of Pharmacy Newsletter Lately, forged prescriptions for either large quantities or high strengths of both OxyContin® and Percocet® have been presented to be filled. The presenters are often young adults or juveniles...

Read More →

Vermont News: Prescribing Schedule II Drugs

Topics: Controlled substances and Prescriptions

Published in the December 2007 Vermont Board of Pharmacy Newsletter The purpose of the memorandum is to answer some questions and clarify a few issues that have recently been brought to the Board’s attention. Topics covered include the Board’s rules...

Read More →

Montana News: Electronic Signature for Controlled Substance Prescriptions

Topics: Controlled substances and Electronic prescriptions

Reprinted from the January 2007 Montana Board of Pharmacy Newsletter. Computer-generated prescriptions, electronic prescribing, and e-signatures are now a reality in daily pharmacy practice. The Board of Pharmacy has adopted rules (24.174.523) that allow for secure electronic signature and transmission...

Read More →

New Jersey News: Requirements for Schedule II CDS Prescriptions

Topics: Controlled substances and Prescriptions

Reprinted from the January 2007 New Jersey Board of Pharmacy Newsletter. Regulations promulgated by the New Jersey Board of Medical Examiners outline the requirements of all written prescriptions in the state of New Jersey, including Schedule II prescriptions. According to...

Read More →

Nebraska News: "Fill After" Prescriptions for Schedule II Controlled Substances Not Valid

Topics: Controlled substances

Published in the January 2007 Nebraska Board of Pharmacy Newsletter There has been some confusion about a Drug Enforcement Administration (DEA) regulation regarding Schedule II prescriptions with “fill after” dates. On August 26, 2005, DEA published a clarification of its...

Read More →

Nevada News: Inspector's Corner

Topics: Controlled substances and Inspection

Reprinted from the January 2007 Nevada State Board of Pharmacy Newsletter. Proper canceling of Schedule II prescriptions: NAC 453.450(3) reads “Each prescription for a controlled substance listed in [S]chedule II must, immediately after filling, be conspicuously cancelled on its face....

Read More →

Washington News: An Update on Electronic Prescriptions for Controlled Substances

Topics: Controlled substances and Electronic prescriptions

Published in the January 2007 Washington State Board of Pharmacy Newsletter Drug Enforcement Administration (DEA) is working to permit electronic prescriptions for controlled substances (EPCS). They have identified some performance standards. The standards include: Authentication: The ability to confirm authenticity...

Read More →

Oklahoma News: From the Inspectors

Topics: Controlled substances, Prescriptions, and Pseudoephedrine

Published in the January 2007 Oklahoma State Board of Pharmacy Newsletter Controlled Dangerous Substances (CDS) Identification (ID) Requirements: As of February 1, 2007, the Oklahoma Bureau of Narcotics & Dangerous Drugs (OBNDD) will be checking for customer IDs on control...

Read More →

Washington News: Schedule II Controlled Substance Prescriptions

Topics: Controlled substances and Prescriptions

Published in the October 2006 Washington State Board of Pharmacy Newsletter A question we frequently receive: In an emergency, can a pharmacist dispense a Schedule II substance with oral authorization from the prescriber? The general rule for Schedule II CS...

Read More →

New Jersey News: Special Exceptions on Narcotic Prescriptions for Chronic Pain Management

Topics: Controlled substances and Pain management

Reprinted from the October 2006 New Jersey Board of Pharmacy Newsletter. A regulation of the New Jersey Board of Medical Examiners permits practitioners to exceed the normal 120 dosage unit or 30-day supply limit (whichever is shorter) when prescribing Schedule...

Read More →

Idaho News: Controlled Substance Prescriptions

Topics: Controlled substances and Prescriptions

Published in the September 2006 Idaho Board of Pharmacy Newsletter After much discussion between the Idaho Board of Pharmacy and the Idaho Pharmacists Association, the following changes were made to Rule 464 concerning the filling of controlled substance (CS) prescriptions....

Read More →

North Carolina News: Item 2122 - Electronic Signatures on Controlled Substance Prescriptions

Topics: Controlled substances, Electronic prescriptions, and Prescriptions

Reprinted from the July 2006 North Carolina Board of Pharmacy Newsletter. Electronic prescribing is an increasing fact of life in pharmacy practice today. Many pharmacists are confused, though, about whether or not and under what circumstances e-prescribing is permissible for...

Read More →

Nebraska News: Reporting Losses of Controlled Substances

Topics: Controlled substances and Diversion

Published in the July 2006 Nebraska Board of Pharmacy Newsletter Immediately upon discovery of a theft or significant loss of CS, a pharmacy must contact the nearest Drug Enforcement Administration (DEA) field office by telephone, fax, or brief written message...

Read More →

South Dakota News: Change to Schedule II Prescribing, Effective July 1, 2006

Topics: Controlled substances and Prescribing authority

Published in the July 2006 South Dakota State Board of Pharmacy Newsletter During the 2006 South Dakota Legislative Session, new language was approved in South Dakota Codified Laws (SDCL) 36-9A-12, 39-9A-13, and 36-4A-22 removing the 48 hour time limit for...

Read More →

Nevada News: Changes to Schedule II Prescriptions

Topics: Controlled substances and Prescribing authority

Reprinted from the July 2006 Nevada State Board of Pharmacy Newsletter. The Board office often receives calls regarding what can be changed on a Schedule II prescription. To clarify, after consulting with the prescribing practitioner (you must speak directly to...

Read More →

Oklahoma News: From the Inspectors

Topics: Controlled substances and Pseudoephedrine

Published in the July 2006 Oklahoma State Board of Pharmacy Newsletter Pharmacists: Please remember that when changing the pharmacy manager, a controlled drug inventory must be taken and sent to the Board within ten (10) days. Also, please include the...

Read More →

Delaware News: Faxing of Controlled Substance Prescriptions

Topics: Controlled substances and Prescriptions

Published in the June 2006 Delaware State Board of Pharmacy Newsletter There have been a number of recent inquiries and some confusion regarding the validity of faxing controlled substance (CS) prescriptions from a practitioner’s office to a pharmacy. The faxing...

Read More →

Kentucky News: Legislation Update 2006

Published in the June 2006 Kentucky Board of Pharmacy Newsletter The Pharmacy Technician Registration Bill (Senate Bill [SB] 110 sponsored by Senator Richard L. Roeding) was passed by a Senate committee and went to the Floor of the Senate, passed...

Read More →

Delaware News: Faxing of Controlled Substance Prescriptions

Topics: Controlled substances, Federal regulations, and Prescriptions

Published in the June 2006 Delaware State Board of Pharmacy Newsletter. There have been a number of recent inquiries and some confusion regarding the validity of faxing controlled substance (CS) prescriptions from a practitioner’s office to a pharmacy. The faxing...

Read More →

South Dakota News: Mid-level Practitioner Legislation

Topics: Controlled substances and Practitioner prescriber

Published in the April 2006 South Dakota State Board of Pharmacy Newsletter Legislation containing revisions related to the prescription of Schedule II controlled drugs by physician assistants, certified nurse practitioners, and certified nurse midwives was signed by Governor Mike Rounds...

Read More →

New Jersey News: Changes in the Prescribing of Controlled Dangerous Substances by Advanced Practice Nurses

Topics: Controlled substances

Reprinted from the April 2006 New Jersey Board of Pharmacy Newsletter. The law (NJSA 45:11-49) regarding prescriptions issued by advanced practice nurses (APN) was amended, effective November 9, 2004, and resulted in modifications being made to the design of New...

Read More →

North Carolina News: Item 2109 - ID Checks and Controlled Substances

Topics: Controlled substances, Patient safety, and Prescribing authority

Reprinted from the April 2006 North Carolina Board of Pharmacy Newsletter. The Board has received several reports of a person calling a pharmacy and having a patient’s controlled substance (CS) prescriptions transferred to a second pharmacy. The caller then picks...

Read More →

Oklahoma News: Annual CDS Inventory

Topics: Controlled substances

Published in the April 2006 Oklahoma State Board of Pharmacy Newsletter Board rules require that “an inventory of all CDS must be taken between May 1 and July 1 of each year. A copy of this inventory will be included...

Read More →

Missouri News: Ephedrine/Pseudoephedrine

Topics: Controlled substances and Pseudoephedrine

Published in the February 2006 Missouri Board of Pharmacy Newsletter As most readers already know, a law dealing with added controls on ephedrine and pseudoephedrine products went into effect in June 2005. Pure ephedrine and pseudoephedrine were classified under state...

Read More →

Montana News: Final Rule: Drug Addiction Treatment Act

Topics: Controlled substances and Prescriptions

Reprinted from the January 2006 Montana Board of Pharmacy Newsletter. On June 23, 2005, a final rule on the Drug Addiction Treatment Act was published. Pursuant to this rule, qualifying physicians (doctor of medicine or doctor of osteopathy) may prescribe...

Read More →

Montana News: Controlled Substance Prescriptions

Topics: Controlled substances and Prescriptions

Reprinted from the January 2006 Montana Board of Pharmacy Newsletter. Pharmacists have a responsibility to ensure that controlled substances (CS) are dispensed pursuant to legitimate medical needs while preventing their diversion into the illicit market. Prescription pads can be stolen,...

Read More →

North Carolina News: Item 2095 - Prescription Order Expiration Date

Topics: Controlled substances, Federal regulations, and Emergency contraception

Reprinted from the January 2006 North Carolina Board of Pharmacy Newsletter. The question has arrived in the Board office as to the existence of an “expiration date” for prescription orders. The only Regulation that would apply to this situation is...

Read More →

Nevada News: Directions for Use

Topics: Controlled substances and Prescription label

Reprinted from the January 2006 Nevada State Board of Pharmacy Newsletter. Nevada Administrative Code 453.015 interprets “directions for use” to require a prescription label to specify the dosage, frequency, and route of administration in which a controlled substance (CS) is...

Read More →